Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder-Reference-Cited by-同舟云学术

Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

Published:2011-04-12 Issue:9 Volume:54 Page:3206-3221
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Bang-Andersen Benny¹,Ruhland Thomas¹,Jørgensen Morten¹,Smith Garrick¹,Frederiksen Kristen¹,Jensen Klaus Gjervig¹,Zhong Huailing²,Nielsen Søren Møller¹,Hogg Sandra¹,Mørk Arne¹,Stensbøl Tine Bryan¹

Affiliation:

1. Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Copenhagen-Valby, Denmark

2. Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652-1431, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm101459g

Reference60 articles.

1. Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

2. Evidence-Based Health Policy—Lessons from the Global Burden of Disease Study